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1. Introduction
Males of many species with either external or internal 
fertilization release their spermatozoa along with seminal 
fl uid. Seminal fl uid is a complex mixture of secretions 
originating from the testis, epididymis and male accessory 
glands such as the seminal vesicles, ampulla, prostate and 
bulbourethral glands (Pilch and Mann 2006). It serves as a 
vehicle that carries ejaculated sperm to the female genital 
tract. A common feature of most seminal plasma proteins 
is their ability to interact with different types of inorganic 
and organic materials present in seminal fl uid (Russell et 
al. 1984; Cameron et al. 2007). Some of these proteins 
are bound to the sperm surface during ejaculation and thus 
protein-coating layers are formed (Varilova et al. 2006). 
In the female reproductive tract, seminal plasma proteins 
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bound to the sperm surface most probably participate 
fi rst in the formation of the oviductal sperm reservoir 
(Evans and Kopf 1998; Jansen et al. 2001); second, in the 
control of sperm capacitation by the intensive action of 
negative (decapacitation factors) and positive regulatory 
(capacitation-stimulating) factors, and fi nally in central 
fertilization events such as sperm–zona pellucida interaction 
and sperm–egg fusion (Primakoff and Myles 2002; Yi et al. 
2007). Seminal plasma proteins have also been shown to 
modulate the immune responses in the uterine environment. 
Thus, the combined effects of seminal plasma components 
support the survival of sperm within the female reproductive 
tract and ensure that functionally competent sperm meets 
the ovulated egg at the site of fertilization (Kanwar et al. 
1979). 
The basic requirement for fertilization to occur is the 
presence of spermatozoa at the site of fertilization and 
their capacitation (Nixon et al. 2007). Another subsequent 
critical step is the acrosome reaction (AR), which is normally 
induced by the zona pellucida as spermatozoa bind to the egg 
(Wassarman 1999). A prerequisite for AR is capacitation, 
which is enhanced by glycosaminoglycans (GAGs) (Handrow 
et al. 1982; Lenz et al. 1983; Parrish et al. 1988). GAGs are 
disaccharide polymeric components of proteoglycans found 
in many tissues. Among the several GAGs tested, heparin is 
the most potent enhancer of capacitation in bovine and rabbit 
spermatozoa (Parrish et al. 1988). It has been previously 
shown that the heparin in seminal fl uid stimulates sperm 
capacitation in bulls. Interestingly, induction of sperm 
capacitation in the female reproductive tract is aided by 
HBPs secreted by the male accessory sex glands (Miller 
et al. 1990). Seminal fl uid HBPs are supposed to attach 
themselves to the sperm surface, especially lipids containing 
the phosphoryl-choline group, thus allowing heparin-like 
GAGs in the female reproductive tract to activate sperm 
capacitation (Miller et al. 1987). Thus, seminal fl uid HBPs 
play a vital role in spermatozoon survival and the overall 
fertilization process, and any alteration in these proteins can 
be directly related to infertility. HBPs have been identifi ed 
in various species, e.g. bovine (Chandonnet et al. 1990), 
equine (Calvete et al. 1995, 1997) and canine (de Souza et 
al. 2006). However, very little attention has been paid to 
the identifi cation and characterization of HBPs from human 
seminal fl uid. We have earlier reported the purifi cation of 
seven HBPs from human seminal fl uid (Kumar et al. 2008). 
In this study, we report the identifi cation of HBPs from human 
seminal fl uid through two-dimensional gel electrophoresis 
(2-DE) and matrix-assisted laser desorption/ionization time-
of-fl ight/mass spectrometry (MALDI-TOF/MS). We believe 
that a thorough analysis of the HBPs in seminal plasma in 
particular will serve as a reference for future studies in basic 
physiology, as well as the discovery of biomarkers of male 
infertility. 
2. Materials and methods
2.1 Chemicals and reagents
Acetonitrile (ACN), methanol, acetic acid, ammonium 
bicarbonate, ammonium dihydrogen phosphate, phosphoric 
acid and sodium hydroxide were obtained from Sisco 
research laboratories (India). Iodoacetamide, urea and 
trifl uoroacetic acid (TFA) were purchased from Sigma 
Aldrich (St Louis, MO, USA). Dithiothreitol (DTT) was 
obtained from GE Healthcare (Uppsala, Sweden). Trypsin 
mass grade was from Sigma Aldrich (St Louis, MO, USA). 
2.2 Sample collection and affi nity chromatography on 
heparin sepharose
Human semen samples were obtained from the Department of 
Laboratory Medicine, All India Institute of Medical Sciences, 
New Delhi. Sample collection and affi nity chromatography 
were performed as described previously (Kumar et al. 
2008). The absorbance of eluted fractions was measured 
at 280 nm. The fractions containing proteins were pooled, 
concentrated and desalted using ultrafi ltration (Amnicon, 
USA), lyophilized and used for the subsequent analysis.
2.3 2-DE
The sample was prepared according to the method described 
previously for crude human seminal plasma proteome 
(Hassan et al. 2007). The eluted fractions obtained from 
a heparin–sepharose CL-6B column were precipitated at 
4°C for 60 min using a precipitation kit according to the 
manufacturer’s protocol (GE-Healthcare Upsala, Sweden). 
Following further centrifugation at 10 000 rpm for 30 min, 
the supernatant was removed and the pellets were washed 
with cold acetone (three times). Protein concentration 
was assessed by the 2D quant kit (GE healthcare, Upsala 
Sweden), and 100 μg protein was resuspended in 2-DE 
rehydration buffer (350 μl, 8 M urea, 2% CHAPS, 18 
mM DTT, 0.5% immobilized pH gradient [IPG] buffer, 
bromophenol blue) and passively rehydrated into 13 cm 
IPG strips (IPG 3–10, GE- Healthcare Upsala, Sweden) 
for 16 h. First-dimension IEF was performed by the IPG 
phorTM system according to the manufacturer’s protocol 
(GE-Healthcare Upsala, Sweden). The instrument was 
programmed for 8 h rehydration, 4 h active rehydration at 30 
V, 1 h at 300 V, 1 h at 8000 V (gradient), and 10 h at 8000 V 
(steady-state level). During the actual run, the fi nal step was 
shortened to only 4–5 h (at 40 000 V h). Upon completion 
of the fi rst dimension, IPG strips were incubated with gentle 
shaking in the equilibration buffer (50 mM Tris-HCl, pH 8.8, 
6 M urea, 30% glycerol, 2% SDS, a trace of bromophenol 
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blue containing 1% DTT) for 15 min. Second-dimension IEF 
was performed on 12% polyacrylamide gels. Gels were run 
for 12–16 h, fi xed, stained with silver stain (16 h) and then 
destained overnight. Destained gels were then scanned using 
an Image ScannerTM fl atbed scanner with Magic ScanTM 32 
software. Gels were analysed using the Image MasterTM 
2-D Elite Software (GE-Healthcare Upsala, Sweden). For 
comparative analysis, the relative intensity of each pair of 
matching spots was measured and the relative abundance 
and differential abundance values were displayed. 
2.4 In-gel digestion of protein spots
The spots from 2-DE were manually excised, destained with 
250 μl of 50 mM sodium thiosulphate and 15 mM potassium 
ferricyanide, washed twice with 500 μl of 50 mM ammonium 
carbonate/50% acetonitrile, dehydrated with 500 μl of 100% 
acetonitrile for 20 min at room temperature, reduced for 
30 min at 56°C with 150 μl of 10 mM DTT in 100 mM 
ammonium bicarbonate, alkylated with iodoacetamide (100 μl 
of 50 mM iodoacetamide in 100 mM ammonium bicarbonate) 
in the dark at room temperature for 30 min. After extensive 
washing with ammonium bicarbonate/100% acetonitrile and 
dehydration, the protein spots were digested at 4°C with 30 
μl of 0.02 μg/μl trypsin (modifi ed porcine TPCK-treated, 
sequencing grade, SIGMA, USA) in 50 mM ammonium 
bicarbonate and incubated at 37°C for 16–18 h (overnight). 
The tryptic peptides were then extracted with 60% acetonitrile, 
1% trifl uoroacetic acid (TFA) and the organic solvent was 
evaporated in a vacuum centrifuge (12 000 g for 30 s) to near 
dryness (10 μl). Five microlitres of the in-gel digest sample 
was then mixed with 5 μl of resuspension solution (50% 
acetonitrile, 0.1% TFA) and gently agitated on a vortex. Of 
the reconstituted in-gel digested sample, 2 μl was then mixed 
with 1 μl of alpha-cyano-4-hydroxycinnamic acid matrix (10 
mg/ml in 50% ACN, 0.1%TFA; Bruker, Daltonics) and spotted 
onto a MALDI-target plate. Analysis was performed directly 
after spotting. 
2.5 MALDI-TOF MS and data analysis
Mass spectra were collected on a Bruker Autofl ex MALDI-
TOF mass spectrometer (Bruker Daltonics) equipped with 
a pulsed 337 nm N2 laser. Operating conditions were: ion 
source 1 = 19.00 kV, ion source 2 = 16.50 kV, lens voltage 
= 8.80 kV, refl ector voltage = 20.0 kV, optimized pulsed 
ion extraction time = 80 ns, matrix suppression = 400 
Da, and positive refl ection mode. Spectra were calibrated 
externally using a standard peptide mixture (angiotensin II 
[1046.5 Da], angiotensin I [1296.7 Da], substance P amide 
[1347.7 Da], bombesin [1619.8 Da], adrenocorticotrophic 
hormone [ACTH] fragment 1–17 [2093.1 Da], ACTH 
fragment 18–39 [2465.2 Da], and somatostatin 28 [3147.5 
Da], Bruker). Peptide monoisotopic signals were analysed 
using the SNAP algorithm, implemented in the FlexAnalysis 
software (Bruker Daltonics). Real data were acquired with 
the help of the WarpLC Software (Bruker Daltonics) for 
automatic TOF-MS spectra acquisition, background signal 
fi ltering, and grouping of signals into a peptide profi le with 
respect to their distribution and intensity. The acquired data 
were searched against non-redundant databases from the 
National Center for Biotechnology Information (NCBI) and 
Swiss-Prot with the automated database-searching program 
using the Mascot search engine version 2.2 (Matrix Science, 
Boston, MA, USA). The following specifi ed parameters 
were applied for database search: database (Swiss-Prot 
v. 51.6); taxonomy (Homo sapiens); proteolytic enzyme 
(trypsin); peptide mass tolerance (25 ppm); fragment mass 
tolerance (0.25 Da); global modifi cation (carbamidomethyl 
[Cys]); variable modifi cation (oxidation [Met]); peptide 
charge state (+1); and maximum missed cleavage (1). The 
criteria used to accept identifi cations included the extent of 
sequence coverage, the number of peptides matched, and the 
probabilistic score (MOWSE score), as indicated in table 1. 
3. Results
3.1 2-D gel analysis and identifi cation
Seventy spots (ranging from 10 to 90 kDa and an isoelectric 
point (pI) of 4–10) corresponding to HBPs were resolved by 
2-DE from normal human seminal fl uid (fi gure 1). These 
spots were excised from the gel, trypsinized and the resulting 
peptides were analysed by MALDI-TOF MS, as described in 
Materials and methods. The masses of monoisotropic peaks 
obtained were used to identify each protein by comparing 
theoretical digestions of proteins by trypsin. Out of the 70 
spots resolved, 60 spots were identifi ed by peptide mass 
fi ngerprinting (PMF) analysis. The list of identifi ed proteins 
is shown in table 1. Ten of the spots failed to give any 
identifi cation, giving an overall identifi cation success rate 
of 86% for this study. A number of the proteins appeared as 
multiple spots on 2-D gel, possibly due to post-translational 
modifi cations, proteolytic breakdown or expression of 
highly related gene sequences. Thus, the 60 spots identifi ed 
corresponded to 40 different proteins. The experiments were 
repeated three times from fi ve different pooled fractions; 
between each of the samples the variation was less than 5%.
3.2 Classifi cation of HBPs
We subsequently grouped all the identifi ed proteins into 
functional clusters using Blast2GO functional annotations 
(Conesa et al. 2005) to defi ne the cellular processes in which 
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Figures 1. 2-D gel analysis of heparin-binding proteins (HBPs) from human seminal plasma. 100 μg of the HBP sample was subjected to 
isoelectric focusing (IEF) using 13 cm pI 3–10 immobilized pH gradient (IPG) strips, followed by second-dimension fractionation on 12% 
polyacrylamide gels and silver stained. Spots from the gels were excised and subjected to in-gel tryptic digestion followed by matrix-assisted 
laser desorption ionization time-of-fl ight mass spectrometry (MALDI-TOF MS) analysis.
Table 1. List of human seminal plasma heparin-binding proteins (HBPs)
Spot 
number(s) Accession 
number
Molecular mass/pI   % Seq. cov/No. of 
peptides matched
Protein name Determined Expected Score
1 Catenin alpha-3 Q9UI47 90/5.3 99.8/5.8 39.20 30.6/3
2 SAPS domain family member 3 Q5H9R7 90/5.4 97.6/4.5 74.50 56.8/9
3 DNA topoisomerase 1 P11387 90/5.9 90.7/9.3 89.3 24.6/22
4 Putative uncharacterized protein 
DKFZp686K139 [fragment]
Q6MZF4 94/7.3 122/6.2 101.0 17.2/10
5 Zinc fi nger protein 225 Q9UK10 82/9.4 82.4/9.1 61.20 20.8/14
6 Matrix metalloproteinase-9 [precursor] P14780 78/5.3 78.4/5.7 61.20 20.8/14
7 Chromodomain-helicase  DNA-binding protein 
3 fragment
Q2TAZ1 78/6.2 73.5/5.7 41.0 18.9/5
8 Lactoferrin P02788 76/9.4 78/8.5 334.0 45.1/26
9 Lactoferrin P02788 76/9.4 78/8.5 244.0 37.2/20
10 Lactoferrin P02788 76/9.4 78/8.5 248.0 42.0/22
11 Lactoferrin P02788 76/9.4 78/8.5 248.0 42.0/22
12 Human chorionic gonadotrophin hormone (hCG) P22888 80/9.2 78.6/8.8 55.00 45.5/5
13 Putative uncharacterized protein 
DKFZp686C12204
Q7Z2Z3 74/5.4 71.0/7.4 89.90 20.8/13
14 Matrix metalloproteinase-2 P08253 72/5.4 73.8/5.26 84.50 30.8/10
15 ATP-dependent DNA helicase   PIF1 Q9H611 70/9.4 69.7/9.8 42.70 23.3/5
16 Human serum albumin P02768 66/6.0 69.3/5.9 89.8 18.8/10
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Table 1. (Continued)
17 Human serum albumin P02768 66/6.0 69.3/5.9 100.0 17.2/9
18 Unnamed protein product 65/9.4 32.80 18.8/3
19 Semenogelin II Q02383 64/5.4 65.4/9.0 64.10 24.6/16
20 Semenogelin II Q02383 65/5.6 65.4/9.0 58.0 32.8/14
21 Semenogelin I P04279 52/5.8 52.1/9.3 54.50 31.3/6
22 Semenogelin I P04279 52/5.9 52.1/9.3 55.9 18.8/5
23 Semenogelin I P04279 52/5.9 52.1/9.3 64.1 17.2/9
24 ATP/GTP-binding protein-like 4 Q5VU57 55/6.0 62.3/8.8 53.10 21.3/12
25 Keratin, type II cytoskeletal 1 P04264 55/6.8 66.0/8.1 81.4 20.2/7
26 Alkaline phosphatase placental-like [precursor] P10696 54/7.1 57.3/5.9 17.2 11.3/2 
27 Zinc-fi nger protein 101 Q8IZC7 50/8.6 50.3/9.6 83.7 26.3/7
28 Fibronectin type 3 Q8TC84 38/5.2 38.3/8.9 74.5 56.8/9
29 Fibronectin type 3 Q8TC84 38/5.3 41.0/9.0 68.2 56.7/4
30 Fibronectin type 3 Q8TC84 37/5.4 37.2/8.4 95.70 54.4/11
31 Zinc-fi nger protein 169 Q5SR55 38/5.8 46.9/9.6 79.10 23.4/ 11
32 Protein-tyrosine phosphatase-like member A Q9HB93 36/6.2 32.7/9.3 42.0 14.5/4
33 Steroid 21-hydroxylase P08686 36/5.2 55.8/7.7 36.30 10.1/4
34 Elongation factor 1-delta P29692 30/5.2 31.1/4.9 32.60 18.9/3
35 Prostate-specifi c antigen precursor Q8IWY3 29/7.2 29.2/9.0 122.0 52.0/6
36 Prostate-specifi c antigen precursor Q8IWY3 29/7.4 29.2/9.0 180.0 59.9/14
37 Prostate-specifi c antigen precursor Q8IWY3 29/7.6 29.2/9.0 129.0 46.8/11
38 Prostate-specifi c antigen P07288 28/7.8 28.7/7.6 109.0 44.3/14
39 Apolipoprotein-I P02647 29/9.3 30.7/5.5 62.0 12.9/6
40 Similar to TIM isoform 1 P60174 28/9.4 26.6/6.4 34.50 14.3/3
41 Ras-related protein Rab-3D O95716 25/5.8 24.2/4.7 65.0 32.9/6
42 Putative uncharacterized protein MGC3196 A0PJW6 24/7.0 22.0/11 44.30 36.0/6
43 Metalloproteinase inhibitor 1 [precursor] P01033 24/7.2 23.1/8.4 38.80 16.3/6
44 Lactoferrin fragment Q8IX02 25/5.8 25/9.4 58.20 18.8/5
45 Lactoferrin fragment Q8IX02 23/6.0 25/9.4 58.2 18.8/5
46 Prostaglandin-H2 D-isomerase P41222 22/6.8 21/7.6 89.80 18.8/10
47 Cystatin-C-precursor P01034 20/7.0 15.7/9.0 113.0 49.1/8
48 Angiogenin [precursor] P03950 17/3.6 16.5/9.7 55.90 18.8/ 5
49 Putative uncharacterized protein P14 Q53TM1 17/4.2 14.5/9.4 34.30 16.5/4
50 Pregnancy-associated endometrial alpha-2-
globulin
Q5T6T0 17/4.6 14.9/7.8 44.30 36.0/6
51 Fibronectin [fragment] O95608 17/5.2 13.3/9.8 140.0 87.1/8
52 Fibronectin [fragment] O95608 17/5.4 13.3/9.8 81.4 72.6/7
53–54 Fibronectin type III domain containing 5 Q7Z676 18/5.5 18.2/5.0 74.30 78.5/7
55 Seminal plasma protein-like-1 Q075Z2 16.5/5.6         15.6/6.8 100.0 17.2/8
56 Serine protease inhibitor Kazal type-2 P20155 17/8.8 9.2/9.3 173.0 46.0/22
57 Kunitz-type protease inhibitor 3 P49223 12/5.4 10.2/6.2 47.2 14.4/6
58 Semenogelin I [fragment] Q6Y806 12/9.5 10.4/9.74 55.0 31.3/8
59 Semenogelin I [fragment] Q6Y806 10/9.4 10.4/9.74 50.6 14.5/6
60 Semenogelin I [fragment] Q6Y808 10/9.4 10.3/9.74 80.2 34.0/7
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they participate (fi gure 2A). The most abundant group 
corresponded to the proteins involved in protein metabolism 
(38%). Twenty per cent of the proteins were involved in 
RNA processing and transcription, 18% in transport and 
structural proteins, and 16% in cell recognition and signal 
transduction. Considering the expression pattern of these 
identifi ed proteins, we found that 18% of the proteins were 
specifi cally expressed in different origins of seminal fl uid. 
Of the proteins, 58% are ubiquitously expressed and no 
expression data in seminal fl uid have so far been described 
for 24% of the proteins identifi ed (fi gure 2B). Therefore, the 
identifi cation of these 24% of proteins in human seminal 
fl uid now provides the fi rst experimental protein expression 
data available.
4. Discussion
In this study, we identifi ed 60 spots out of 70 resolved 
spots corresponding to the HBPs extracted from normal 
human seminal fl uid. These 60 spots corresponded to 
40 different proteins. Based on their probable functions, 
these proteins were grouped into four major functional 
categories: (i) enzymes (22 proteins), (ii) RNA processing 
and transcription (12 proteins), (iii) transport and structural 
proteins (10 proteins), and (iv) cell recognition and signal 
transduction (7 proteins). 
To validate their heparin-binding activity, we conducted 
kinetic studies using surface plasmon resonance methods. 
HBPs such as semenogelin I, semenogelin II, fi bronectin 
fragment, lactoferrin and prostate-specifi c antigen (PSA) 
were passed through immobilized biotinylated heparin. The 
binding constants (K
A
 and K
D
) were in the range of 104–109 
1/M and 10–6–10–10 M (results not shown). A few of the 
identifi ed proteins have also been previously reported as 
HBPs, such as lactoferrin (Mann et al. 1994), fi bronectin 
(Walker and Gallagher 1996) and PSA (Hessick et al. 
2005). Various studies have reported that heparin-binding 
sites consist of clusters of basic amino acid residues such 
as XBBXBX, XBBBXXBX (Cardin and Weintraub 1989), 
BBXB (Mann et al. 1994; Proudfoot et al. 2001), XBBX, 
XBBBX and BXXB (Fromm et al. 1997), where B is a basic 
amino acid and X can be any amino acid. Sequence analysis 
of all the HBPs identifi ed in our study revealed that most 
of them have such clusters of basic residues. Though we 
have shown the clusters of BBXB (table 2), some of these 
sequences also contain other reported consensus sequences 
rich in basic residues. 
The fi rst major group of HBPs includes a number of 
enzymes engaged in catalytic activities (38%). This large 
number of enzymes, especially proteases present in seminal 
plasma as HBPs, is not surprising as it has been described 
that almost 60% of the seminal fl uid proteome is involved 
in enzymatic activity (Povoa 1962; Pilch and Mann 2006). 
Much evidence has been provided to show that proteases 
may be active partners in establishing and maintaining 
testicular architecture, and in facilitating germ cell migration 
throughout the spermatogenic developmental processes. 
To prevent unwanted proteolysis and keep these sperm 
proteases in an inactive state, these proteolytic enzymes are 
strongly regulated by protease inhibitors present in seminal 
Figure 2. (a) Classifi cation of human seminal plasma heparin-binding proteins (HBPs) into functional groups as a percentage of the total 
number of proteins identifi ed. (b) Expression profi le of human seminal plasma HBPs 
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plasma. Protease inhibitors are present in the seminal fl uid of 
many mammalian species, for example, human (Schiessler 
et al. 1976; Fink et al. 1990), bull (Cechova and Fritz 
1976; Fritz et al. 1976) and boar (Veselsky et al. 1985), 
and they have been shown to play an important role in male 
fertility. They are also involved in regulation, processing 
or degradation of seminal fl uid proteins and coagulation 
of semen (Zheng et al. 1994; He et al. 1999). A challenge 
for the future will be to identify the full complement of 
proteases and their regulatory mechanisms. This will enable 
the design of additional studies to precisely defi ne the role 
and relative importance of each in the complex steps of testis 
development and spermatogenesis.
The next most abundant group of proteins identifi ed 
corresponds to those involved in RNA processing and 
transcription (20%). This fi nding was not surprising as 
the majority of these proteins are nuclear or intracellular 
in origin. Within this group, DNA-dependent Cys2 His2
zinc-fi nger proteins (ZFPs) accounted for the majority. In 
mammals, ZFPs probably constitute the largest families 
of transcription factor. The identifi ed ZFPs contain Cys2 
His2 zinc-fi nger motifs and at least one Kruppel-associated 
box (KRAB) domain. This Kruppel-related zinc-fi nger 
motif is present in approximately 3% of the proteins 
encoded by mouse and human genomes. This family 
effectively represses transcription through interaction 
with transcriptional intermediary factor 1β (TIF1β), a 
transcriptional co-repressor involved in gene silencing 
through heterochromatin formation (Looman et al. 2002; 
Urrutia 2003). The potential explanation for the proteins 
involved in transcription is that these proteins may be 
leftovers of the spermatogenesis process or may have 
important, but unknown, functions related to the fertilization 
and development of spermatozoa.
The third category of proteins consists of structural and 
transport proteins (18%). Among all structural proteins, 
the most abundant are gel-forming proteins secreted 
by the seminal vesicles: semenogelin I, semenogelin 
II and fi bronectin, which are cleaved by kallikrein-like 
proteases. They form a viscous gel, entrapping spermatozoa 
immediately after ejaculation to provide protection from 
physical damage. The most abundant transport protein 
is lactoferrin, which is present in solution and has an 
antimicrobial role to play in seminal fl uid. Lactoferrin binds 
Table 2. Sequence analysis of human seminal plasma heparin-binding proteins (HBPs)
Identifi ed HBP Clusters of BBXB (B=basic amino acid, X=any other amino acid)
Catenin alpha 3
48
KKGR, 
324
HRER, 
352
KKER, 
368
KKTR, 
681
KKVK, 
878
KKIH
SAPS domain family member 3
144
KKKH, 
257
HKEK 
DNA topoisomerase 1
39
KKEK, 
103
KKEK, 
150
KKIK, 
158
KKEK, 
174
KKPK, 
448
RRLK
Putative uncharacterized protein DKFZp686K139[fragment]
65
RRLR, 
244
RRPH, 
621
HKRH
Zinc-fi nger protein 225
251
RKLH, 
342
KRYK, 
389
RHVR, 
503
RRVH, 
531
RRVH, 
587
KRLH, 
687
KRYK
Chromodomain-helicase-DNA-binding protein 3 fragment
2
KRVR, 
322
HRER, 
402
HRRH, 
456
RRFK, 
632
KKEK
Lactoferrin
2
RRRR, 
28
RKVR, 
342
RRAR
Matrix metalloproteinase-2
98
RKPR, 
115
RKPK
ATP-dependent DNA helicase PIFI
158
RRLR, 
615
RRGR
Human serum albumin
33
HRFK, 
183
KRYK, 
559
HKPK
Semenogelin I
296
RRLH, 
356
RRLH, 
425
RHQH
Semenogelin II
281
RKAH
ATP/GTP-binding protein-like 4
464
RKEK
Alkaline phosphtase placental-like [precursor]
78
KKDK
Zinc-fi nger protein 101
119
RHMR, 
141
RKQK, 
214
KHGK, 
299
RHER, 
357
KKTH
Fibronectin type 3
43
KKAK, 
335
KKQR
Zinc-fi nger protein 169
106
RHFR, 
118
KRIH, 
228
RHQR, 
284
RHQR, 
311
RHQR, 
368
RHQR, 
398
RRTK
Steroid 21-hydroxylase
224
RRLK, 
232
KRDH
Elongation factor 1-delta
185
KKAK
PSA precursor
196
RKYR
RAS-related protein RAB-3D
66
RHDK
Pregnancy-associated endometrial alpha-2-globulin
61
KKFK
Fibronectin type III domain containing 5
27
RHLK
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to the sperm surface membrane during ejaculation, and 
seems to be a major sperm-coating antigen (Goodman et al. 
1981). It has been suggested that the affi nity of lactoferrin 
for sperm and its potential role in protecting sperm from the 
immunocompetent environment of the female reproductive 
tract might be regulated by its clustering with some of the 
other proteins of seminal plasma (Thaler et al. 1990). Serum 
albumin, an important constituent of seminal plasma that has 
a role as a sink for cholesterol, is removed from the sperm 
membrane during capacitation (Mortimer et al. 1998; Bedu-
Addo et al. 2005). 
Among the identifi ed proteins, seven of these are 
involved in cell recognition and signal transduction (fi gure 
2a). These proteins are consistent with the functions required 
for sperm capacitation, interaction with the zona pellucida, 
acrosomal reaction and oocyte penetration. This group 
includes cadherin-associated protein, Ras-related Rab 3D, 
keratinocyte growth factor, mitogen-activated protein kinase 
kinase kinase (MLT) and elongation factor 1delta. We 
also identifi ed fi ve proteins (8%) with unknown function. 
However, the expression of some of these proteins in the 
testes and prostate is well known. 
Proteins that have been previously described as HBPs, 
for example, protein C inhibitor (PCI) and its complex with 
PSA (Suzuki et al. 2007; Espana et al. 1991), hepatocyte 
growth factor (HGF) (Schwall et al. 1996; Sakata et 
al. 1997), phospholipase A2 (PLA2) (Bugs et al. 2005)
and human spermadhesins-like (hsa) proteins (Kraus et al. 
2001) were not detected in our study. Thus, we conclude
that our experimental approach has permitted the 
identifi cation of a signifi cant number of new HBPs but
some of them still escape detection by this approach, 
possibly due to the type of sample used for the experiments 
or the amount of these proteins in the sample. Thus,
in the near future, further investigations using samples
from different species will probably add to the list of new 
HBPs.
In summary, proteomic analysis of body fl uids, especially 
human seminal plasma, is of great interest and has potential 
clinical implications. We have offered a proteomic strategy 
based on affi nity chromatography followed by 2-DE, in 
conjunction with subsequent enzymatic digestion followed 
by MALDI-TOF/MS. This has been demonstrated to
be a promising alternative approach for protein identifi cation 
in complex body fl uids. Our strategy proved to be robust,
easy to use, and less work intensive than traditional 
proteomic approaches. The combination of proteomic 
analysis and functional studies will be a successful tool 
to discover new cellular pathways in which HBPs may 
be involved. Moreover, the identifi cation of such proteins 
in seminal plasma could provide better insights into the 
physiological processes and the nature of subfertility or 
infertility. 
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